febuxostat
ItalyDrugs containing this active substance
-
It is used to treat gout by reducing uric acid levels in the body. The 120 mg version is also used to prevent excess uric acid during chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.
-
It is used to treat gout, a disease caused by an excess of uric acid in the body. The 120 mg version is also used to prevent and treat high uric acid levels that may occur during chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: SO.SE.PHARM S.R.L. SOCIETA' DI SERVIZIO PER L'INDUSTRIA FARMACEUTICA ED AFFINI
-
It is used to treat gout by reducing uric acid levels in the body. The 120 mg version is also used to prevent excess uric acid in those undergoing chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: DYMALIFE PHARMACEUTICAL S.R.L.
-
It is used to treat gout, a disease caused by an excess of uric acid in the body. The 120 mg version is also used to prevent an increase in uric acid levels during chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.
-
It is used to treat gout, a disease caused by an excess of uric acid in the body. The 120 mg version is also used to prevent and treat increases in uric acid levels in those undergoing chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: DOC GENERICI SRL
-
It is used to treat gout, a disease caused by an excess of uric acid in the body. The 120 mg version is also used to prevent an increase in uric acid levels in those undergoing chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: KRKA D.D. NOVO MESTO
-
It is used to treat gout, a disease caused by an excess of uric acid in the body. The 120 mg version is also used to prevent an increase in uric acid levels in those undergoing chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: TOWA PHARMACEUTICAL S.P.A.
-
It is used to treat gout, a disease caused by an excess of uric acid in the body. The 120 mg version is also used to prevent and treat the increase in uric acid levels that can occur during chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: SANDOZ S.P.A.
-
It is used to treat gout, a disease caused by an excess of uric acid in the body. The drug works by reducing uric acid levels, helping to prevent crystal buildup and reducing symptoms.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: TECNIGEN S.R.L.
-
It is used to treat gout, a disease caused by excess uric acid in the blood, by reducing the levels of this substance. The 120 mg version is also used to prevent increases in uric acid in those undergoing chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: TEVA B.V.
-
It is used to treat gout, a disease caused by an excess of uric acid in the body. The 120 mg version is also used to prevent an increase in uric acid levels during chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: VIATRIS LIMITED
-
The medicine is used to treat gout by reducing uric acid levels in the body. The 120 mg version is also indicated to prevent the increase in uric acid levels that can occur during chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: S.F. GROUP S.R.L.
-
This medicine is used to treat gout, a disease caused by an excess of uric acid in the body. The 120 mg version is also indicated to prevent and treat high uric acid concentrations that may occur following chemotherapy for blood cancers.
Form: tablets, film-coated
Active substance Dosage febuxostat - ATC: M04AA03
Manufacturer: LABORATORIO FARMACEUTICO C.T. S.R.L.